Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Browse Articles or use Lyrarc's US patented "Groups" and "Links" for new insights. A Lyrarc Group of Articles on a topic gives insights into particular angles shown in the Group Title. A Lyrarc Link shows more specific insights for 2 articles.
Sushasan- Good Governance, and Surakshan- Rule of Law, for the first time since independence in 1947 India's largest state with a population of 250 million people is being transformed. This creates the right climate for domestic and foreign investment. The Swachh Bharat (Clean India) and Jal Jeevsn missions for water, electricity for every home projects provide the underpinnings of future development.
Linked Articles
The Indian Express 09/20/2021
In Uttar Pradesh, does the BJP have an edge?Hindustan Times 09/20/2021
Linked Articles
How a Couple’s Quest to Cure Cancer Led to the West’s First Covid-19 Vaccine
WSJ 12/02/2020
Pfizer Gets $1.95 Billion to Produce Coronavirus Vaccine by Year’s EndNYTimes.com 07/22/2020
Rathmann's focus on EPO when Amgen was near bankruptcy in the mid-1980's saved the company. By 1989 Amgen had secured FDA approval for Epogen, a hormone based drug to stimulate the production of red blood cells. This is a rare success in a biotech industry with many failed startup ventures or ventures strugglig with only 6-12 months of cash remaining.
Linked Articles
Cash Dries Up for Biotech Drug Firms
Wall Street Journal 03/16/2009
Amgen's First CEOWall Street Journal 04/23/2012
Linked Articles
Opinion: PLI scheme - achieving the goal
mint 12/16/2020
‘Pushing India to surpass China in mobile manufacturing’: Ravi Shankar PrasadHindustan Times 12/16/2020
Drug companies have $155 billion they plan to use for mergers and acquisitions and are tapping the bond markets for funds. Meantime small biotech startups are running short of cash in large numbers. Will this squeeze innovation and new products as startups wither and the mergers run into problems?
Linked Articles
Drug Firms Bet Big on High-Risk Deals
Wall Street Journal 03/17/2009
Cash Dries Up for Biotech Drug FirmsWall Street Journal 03/16/2009
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1